Loss of the autoimmune risk gene TREX1 reveals a convergence of mechanisms promoting immune tolerance loss and antitumor immunity
Junghyun Lim, Klaus Heger, Merone Roose‐Girma, Barzin Y. Nabet(Gene Therapy Laboratory), Sören Müller(Genesys (United States)), Janice Corpuz, Edward Dere, Sascha Rutz(Gilead Sciences (United Kingdom)), Ryan Rodriguez(Translational Research in Oncology), Soyoung Oh, Shari Lau, Grace Barnett, Søren Warming(Genesys (United States)), Mayra Cruz Tleugabulova, Nathaniel R. West(Gene Therapy Laboratory), Stephanie Mittman(Translational Research in Oncology), Jeffrey Hung, Prashant Desai, J. Lau, Paul Tyler, Katherine Williams, Marco De Simone, Serena Y. Lee, Lucinda Tam, Annie Ogasawara, James Ziai, Elizabeth T. Carbone, Smadar Shiffman, Thomas F. Brewer, Simon Williams, Meng Xiao He, Haruka Murota, Kevin A. Marroquin, Herman Gill, Yan Qu, Patricia Pacheco Sanchez, Bridget Hough, Leah Schutt
Cited by 0
Related Papers
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
|Cancer Cell|2021|930
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
|Cell|2014|798